Replies to post #124864 on Biotech Values

[oc631]

Please be more specific—who said what, exactly? I suspect that you misinterpreted what was said because it makes no sense for IDIX to run that many phase-2 studies just to reach a go/no-go decision on taking IDX184 to phase-3.

Yeah I'm quite certain. It's during the Q/A session. Did you listen to the call?